JENNIFER MILEY: Open Payments
NPI 1154338424 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 50 payments from 14 companies in 2025. Trend: 2023 $1,469 · 2024 $1,433 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $184 |
| PFIZER INC. | 10 | $162 |
| Novo Nordisk Inc | 5 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $135 |
| Astellas Pharma US Inc | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
Products named: Wegovy, AIRSUPRA, QULIPTA, NURTEC ODT, ELIQUIS, Veozah, MOUNJARO, VRAYLAR.
Industry payments across FL — which companies pay providers there.
